Reports 6 Min Read
Life Science R&D leaders and CIOs are at a critical inflection point, facing immense pressure to differentiate their organizations through strategic adoption of AI, multiomics, and cloud platforms, all while navigating a complex landscape characterized by exponential data growth, regulatory scrutiny, and tight budget constraints to identify and invest in emerging technologies that will deliver true transformational ROI in the shift toward precision medicine.
We believe this strategic Gartner report serves as your definitive roadmap to time your investments, mitigate risk, and scale the innovations that drive true scientific discovery.
Download the report to discover:
The 2026 technology priority investments for Life Science CIOs.
How to transition from “Document-Centric” to “Data-Centric” R&D.
Which technologies are maturing and ready for immediate adoption.
Gartner, Hype Cycle for Life Science R&D, 2025, 7 July 2025, Reuben Harwood, Jeff Smith